The earnings call reflects a positive start to the year with revenue and EBITDA exceeding expectations and strong growth in consumables. However, there are significant challenges, including a substantial decline in equipment sales, regional revenue declines, and the impact of tariffs on operations in China. Despite these challenges, the company's strategic initiatives and strong product launches provide a positive outlook.

Company Guidance -

Q2 2025

During the Beauty Health Company's Q1 2025 earnings call, CEO Marla Beck highlighted that the company exceeded revenue expectations, reporting $69.6 million compared to their guidance. The adjusted EBITDA was over $7 million, driven by a favorable shift toward high-margin consumables, which grew over 8% and now represent more than 70% of total revenue. The company saw an increase in active devices to over 35,000 units, up from approximately 32,500 units in Q1 2024, indicating strong demand for Hydrafacial devices. Adjusted gross margin was reported at 71.9%, a significant improvement from the previous year. Looking forward, the company maintained its full-year 2025 sales guidance between $270 million and $300 million, with adjusted EBITDA projected at $15 million to $25 million, despite macroeconomic pressures impacting equipment sales.

Exceeding Revenue and EBITDA Guidance

The company exceeded its revenue expectations at $69.6 million, above the high end of its guidance, and delivered over $7 million of adjusted EBITDA.

Strong Consumable Sales

Consumables grew over 8% and now represent over 70% of the company's revenue. Consumable net sales increased 3.5% in the Americas, 42.6% in APAC, and 7.9% in EMEA.

Successful Product Launches

The Hydralock HA booster launched in the second half of 2024 marked the most successful branded booster launch in the company's history.

Improved Gross Margin

Adjusted gross margin for the quarter was 71.9% compared to 63.4% in the prior year period, driven by a favorable mix towards consumable net sales and improved operational processes.

Increased Active Devices

Total active devices in the field increased to over 35,000 units versus approximately 32,500 units at the end of Q1 2024.

Beauty Health (SKIN) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

SKIN Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Aug 07, 2025	2025 (Q2)	-0.05 / -	-0.057	―	―	―
May 08, 2025	2025 (Q1)	-0.13 / -0.08	-0.01	-700.00% (-0.07)
Mar 12, 2025	2024 (Q4)	-0.11 / -0.08	-0.028	-185.71% (-0.05)
Nov 12, 2024	2024 (Q3)	-0.09 / -0.15	-0.5	70.00% (+0.35)	―
Aug 08, 2024	2024 (Q2)	-0.01 / -0.06	0.061	-193.44% (-0.12)	―
May 09, 2024	2024 (Q1)	-0.10 / -0.01	-0.042	76.19% (+0.03)	―
Mar 12, 2024	2023 (Q4)	-0.07 / -0.03	0.056	-150.00% (-0.08)	―
Nov 13, 2023	2023 (Q3)	0.07 / -0.50	0.052	-1061.54% (-0.55)	―
Aug 09, 2023	2023 (Q2)	0.05 / 0.06	0.012	408.33% (+0.05)
May 10, 2023	2023 (Q1)	-0.03 / -0.04	-0.048	12.50% (<+0.01)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

SKIN Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
May 08, 2025	$1.24	$1.87	+50.81%
Mar 12, 2025	$1.42	$1.34	-5.63%
Nov 12, 2024	$1.70	$1.85	+8.82%
Aug 08, 2024	$1.29	$1.12	-13.18%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.